About Our Lymphoma eConsult Program with Nebraska Medicine

Our leadership team has been working closely with Nebraska Medicine to start a few new collaborative efforts that bring more specialized options to our patients here at our Cancer Center. One example of this is the new eConsult Program.

At this time we are piloting the eConsult Program with just leukemia and lymphoma patients. We have always encouraged second opinions if patients wanted one and the eConsult Program is a convenient option for our most complex leukemia and lymphoma cases that saves them the time and cost of going to a second facility.

Here is more information about the program:

What is an eConsult?

The eConsult program lets your June E. Nylen Cancer Center oncologist consult with specialists throughout Nebraska Medicine and come up with a care plan just for you.

What are the benefits of eConsults?

eConsults are an easy and efficient way of seeing a Nebraska Medicine oncologist or specialty care provider. By reviewing your medical chart, they can oftentimes give a second opinion in making a diagnosis and building a treatment plan for you without you ever needing to go to their medical office in Omaha. The technology is safe with strict patient privacy standards used for the physician eConsult.

How will you get your results?

Your Nylen Cancer Center oncologist will follow up with you about your eConsult.

What is the cost?

An eConsult is thought of as a separate medical visit and, as such, there can be a fee for this visit. Most major insurers cover the cost of eConsults (or second opinions); however, for those not covered by insurance there will be a charge to ask for the consult and to cover the expense of the Nebraska Medicine’s specialist to review your records and give personal answers for your condition.

In some cases, Nebraska Medicine may need to get the pathology slides from your biopsy and there would be a charge for the review of the biopsy material. Again, this would be sent to your insurance, however; any amount not covered would be your responsibility.

Will I still need to see a specialist in person?

Most medical conditions can be handled by the eConsult program; however, there might be times in which the Nebraska Medicine specialist needs to see you in person. In this case your eConsult fee will be waived and a priority visit will be scheduled for you at their Omaha office.

Meet the UNMC eConsult oncologist for leukemia and lymphoma patients - julie m. vose, md, mba

Julie M. Vose, MD, MBA, is the Neumann M. and Mildred E. Harris Professor and Chief of the Division of Oncology/Hematology at the University of Nebraska Medical Center in Omaha, Nebraska. In addition, she is a past president of the American Society of Clinical Oncology.

Dr. Vose received her medical degree, completed her residency in internal medicine as chief resident, and completed a fellowship in hematology and oncology at the University of Nebraska Medical Center. In addition, she completed a sabbatical at Stanford University, and continued her education by obtaining an MBA in Health Administration from the University of Colorado Business School.

Dr. Vose has focused her career on translational research improving the therapy of non-Hodgkin’s lymphoma (NHL) and Hodgkin’s lymphoma by developing a focused translational research program evaluating novel therapies, such as radiolabeled monoclonal antibodies, idiotype vaccine therapies, pathway-directed agents, stem cell transplantation, and CAR T-cell therapy. Further, her funding record and publications in NHL therapy and transplantation research have substantially added to the research
and knowledge base for lymphoma therapy. As a result of her NHL research, Dr. Vose has been recognized nationally and internationally through worldwide research awards and invited lectureships.